<code id='68657CF56C'></code><style id='68657CF56C'></style>
    • <acronym id='68657CF56C'></acronym>
      <center id='68657CF56C'><center id='68657CF56C'><tfoot id='68657CF56C'></tfoot></center><abbr id='68657CF56C'><dir id='68657CF56C'><tfoot id='68657CF56C'></tfoot><noframes id='68657CF56C'>

    • <optgroup id='68657CF56C'><strike id='68657CF56C'><sup id='68657CF56C'></sup></strike><code id='68657CF56C'></code></optgroup>
        1. <b id='68657CF56C'><label id='68657CF56C'><select id='68657CF56C'><dt id='68657CF56C'><span id='68657CF56C'></span></dt></select></label></b><u id='68657CF56C'></u>
          <i id='68657CF56C'><strike id='68657CF56C'><tt id='68657CF56C'><pre id='68657CF56C'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          focus

          author:entertainment    - browse:991
          Christine Kao/STAT

          There’s a specter haunting Wall Street.

          It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

          advertisement

          Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          entertainment